Enrollment to clinical trials for prevention of migraine-type headache
Biohit Oyj Press Release May 20, 2014 at 2:15 pm local time (EEST) Biohit Oyj initiates two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule in novel clinical indications. The purpose of the trial is to assess the effect of Acetium® capsule in prevention of headache attacks among patients suffering from migraine or cluster/Horton headache. Both studies will be conducted as multi-center clinical trials in collaboration with Terveystalo Oy and Aava Medical Center altogether in six cities in Finland. Enquiries and enrollment: